Skip to main content
. 2022 Jul 22;14:931015. doi: 10.3389/fnagi.2022.931015

TABLE 1.

Clinical and demographic data of the PET/MR cohort.

Age (y) Gender Disease Duration (m) H-Y Scale UPDRS III MoCA HAMA HAMD-24 RBDQ-HK
HC (N = 31) 57.45 ± 10.52 16F/15 M 0.42 ± 1.31 25.10 ± 3.76 3.00 ± 4.86 1.93 ± 3.12 4.30 ± 5.68
(36–71) (0–4) (14–30) (0–25) (0–14) (0–25)
PD (N = 34) 58.29 ± 13.90 16F/18 M 39.47 ± 40.69 1.77 ± 0.70 22.00 ± 11.75 26.65 ± 3.07 7.43 ± 8.14 6.73 ± 10.73 14.13 ± 14.25
(26–86) (6–171) (1.0–4.0) (7–55) (16–30) (0–39) (0–58) (0–53)
P 0.41 0.84 <0.05 0.20 <0.05 <0.05 <0.05

H-Y Scale, Hoehn-Yahr scale; UPDRS III, motor score of unified Parkinson’s Disease rating scale; MoCA, Montreal cognitive assessment; HAMA, hamilton anxiety scale; HAMD-24, 24-item hamilton depression rating scale; RBDQ-HK, rapid eye movement sleep behavior disorder questionnaire-Hong Kong. Data are presented as mean ± SD, with ranges in parentheses.